REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSENS.L Regulatory News (SENS)

  • There is currently no data for SENS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI)

12 Apr 2022 08:31

RNS Number : 0991I
Liberum Capital Limited
12 April 2022
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Liberum Capital Limited

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Sensyne Health PLC

(c) Name of the party to the offer with which exempt principal trader is connected:

Sensyne Health PLC

(d) Date dealing undertaken:

11th April 2022

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

No

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

 

ORD 10p

 

Purchase

 

 

98,129

 

0.019

 

0.019

 

ORD 10p

 

Sale

 

 

184,619

 

0.021

 

0.02

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

 

Date of disclosure:

12th April 2022

 

Contact name:

Rajvinder Mahil

Telephone number:

020 3100 2213

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FERGRGDSCDBDGDD
Date   Source Headline
31st Jul 20197:00 amRNSCollaboration Agreement with Bayer
9th Jul 20197:00 amRNSHoldings in Company
1st Jul 20192:05 pmRNSSecond Price Monitoring Extn
1st Jul 20192:00 pmRNSPrice Monitoring Extension
27th Jun 20194:48 pmRNSHolding(s) in Company
27th Jun 20194:42 pmRNSHolding(s) in Company
25th Jun 20197:00 amRNSEY announcement on AI and blockchain
24th Jun 20197:00 amRNSLAB10x partnership for data-driven drug discovery
30th Apr 20197:00 amRNSBayer joins Sensyne Health consortium
28th Jan 20197:02 amRNSResearch alliance with Big Data Institute
28th Jan 20197:02 amRNSAgreement with Jefferson Health in US
28th Jan 20197:02 amRNSSigns SRA with Wye Valley NHS Trust
28th Jan 20197:02 amRNSSigns SRA with George Eliot Hospital NHS Trust
28th Jan 20197:02 amRNSSensyne Health Maiden Interim Results 2018
15th Jan 20197:00 amRNSNotice of Interim Results
5th Dec 201810:41 amRNSAnnouncement on National Health Data
21st Nov 20187:00 amRNSStrategic advisory services agreement with EY
24th Oct 20187:00 amRNSBoard Change
16th Oct 20187:00 amRNSOfficial product launch of GDm-HealthT
3rd Oct 20187:00 amRNSBoard Appointment
2nd Oct 20187:00 amRNSChange of Registered Office
28th Sep 201811:56 amRNSHolding(s) in Company
6th Sep 20181:19 pmRNSSensyne Health welcomes government code of conduct
21st Aug 20183:28 pmRNSHoldings in Company
20th Aug 20185:32 pmRNSHoldings in Company
20th Aug 20184:52 pmRNSHoldings in Company
17th Aug 20188:04 amRNSAdmission to AIM & First Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.